Sara Semnani

Partner
Full contact info

Experience

Kyverna Therapeutics Closes $85 Million Series B

January 28, 2022

Cooley advised Kyverna Therapeutics on its $85 million Series B financing. Partners Laura Berezin and Sara Semnani led the Cooley team advising Kyverna, a developer of new cell-based therapeutics designed to offer treatments and cures for serious autoimmune and inflammatory diseases.

Related contacts

Laura Berezin
Partner, Seattle
Sara Semnani
Partner, Los Angeles Santa Monica
Han Wang
Associate, Los Angeles Santa Monica
Amy Saldamando
Paralegal Specialist, Los Angeles Santa Monica

Related Practices & Industries

The Honest Company – $475 Million IPO

May 10, 2021

Cooley advised The Honest Company, a consumer goods company founded by actress Jessica Alba, on its $475 million initial public offering of 29,678,050 shares of common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. Partners Tom Hopkins, Nicole Brookshire, Siana Lowrey and Sara Semnani led the Cooley team advising Honest.

Read more

Related contacts

C. Thomas Hopkins
Partner, Los Angeles Santa Monica
Siana Lowrey
Partner, San Francisco
Sara Semnani
Partner, Los Angeles Santa Monica
Carlos Ramirez
Partner, San Diego
Jessica Girone
Associate, Los Angeles Santa Monica
Barbara Mirza
Partner, Los Angeles Santa Monica
Austin Holt
Partner, Los Angeles Santa Monica
Megan Drill
Associate, San Diego
Xander Lee
Partner, Los Angeles Santa Monica
Natasha Leskovsek
Of Counsel, Washington, DC
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
John Paul Oleksiuk
Partner, New York
David Navetta
Partner, Colorado
Kristopher Kleiner
Special Counsel, Colorado
Amy Saldamando
Paralegal Specialist, Los Angeles Santa Monica
TJ Graham
Partner, Palo Alto
Ross Eberly
Partner, Los Angeles Santa Monica
Eileen Leman
Associate, Los Angeles Downtown
Jacqueline Grise
Partner, Washington, DC
Sharon Connaughton
Special Counsel, Washington, DC
David Burns
Special Counsel, Washington, DC
Matt Howsare
Partner, Washington, DC
Scott Dailard
Partner, San Diego
Francis Wheeler
Partner, Colorado
Karen Tsai
Special Counsel, Washington, DC
Maricel Mojares-Moore
Special Counsel, San Francisco
Greg Reith
Associate, Washington, DC
Chris Rhem
Paralegal Specialist, San Francisco
Pilar Brito
Associate, Los Angeles Santa Monica

Related Practices & Industries

Ovid - $75 Million IPO

December 1, 2020

Cooley advised Ovid on its $75 million initial public offering of 5,000,000 shares of common stock. Ovid, which now trades on The NASDAQ Global Select Market as “OVID,” is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders.

Read more

Related contacts

Laura Berezin
Partner, Seattle
Div Gupta
Partner, New York
Jaime L. Chase
Partner, Washington, DC
Sara Semnani
Partner, Los Angeles Santa Monica
Jeramie Perez
Senior Paralegal, Palo Alto
Jason Minio
Paralegal Specialist, Boston
Natasha Leskovsek
Of Counsel, Washington, DC
Phil Mitchell
Partner, New York
Ivor Elrifi
Partner, New York
Heidi A. Erlacher
Partner, Boston
David Walsh
Partner, Reston
Mary Maher Lewis
Special Counsel, Reston
Francis Wheeler
Partner, Colorado

Related Practices & Industries

Vir Biotechnology - $143 Million IPO

October 17, 2019

Cooley advised Vir Biotechnology on its $142.9 million initial public offering of 7,142,858 shares of common stock. Vir Biotechnology, whose securities now trade on Nasdaq Global Select Market under the symbol "VIR", is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Partners Laura Berezin, Charlie Kim and Kristin VanderPas led the Cooley team.

Related contacts

Laura Berezin
Partner, Seattle
Charlie Kim
Partner, San Diego
Kristin VanderPas
Partner, San Francisco
Sara Semnani
Partner, Los Angeles Santa Monica
Carlos Ramirez
Partner, San Diego
Chen Chen
Associate, Palo Alto
Sarah Choi
Associate, Los Angeles Santa Monica
Karen Tsai
Special Counsel, Washington, DC
Mary Maher Lewis
Special Counsel, Reston
Xander Lee
Partner, Los Angeles Santa Monica
Francis Wheeler
Partner, Colorado
Ivor Elrifi
Partner, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Rick Jantz
Associate, Los Angeles Santa Monica
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Phil Mitchell
Partner, New York
Wendy Brenner
Partner, Palo Alto
Koji Fukumura
Partner, San Diego
Kate Hillier
Partner, Seattle
David Burns
Special Counsel, Washington, DC
Selin Akkan
Associate, Palo Alto

Related Practices & Industries

Kezar Life Sciences – $86 Million IPO

May 2, 2017

Cooley advised Kezar Life Sciences Inc. on its $86.3 million initial public offering of 5,750,000 shares of common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. Cooley partners Laura Berezin and Rob Phillips led the team advising Kezar.

Jefferies and Cowen and Company acted as joint book-running managers for the offering. Wells Fargo and William Blair also acted as book-runners. 

Kezar is a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. It now trades on the Nasdaq Global Select Market under the symbol “KZR.”

Related contacts

Laura Berezin
Partner, Seattle
Jaime L. Chase
Partner, Washington, DC
Sara Semnani
Partner, Los Angeles Santa Monica

Related Practices & Industries

View more